接合 发表于 2025-3-23 09:49:13

http://reply.papertrans.cn/2/123/12298/12298-11.png

疯狂 发表于 2025-3-23 17:39:41

Submitted on: 26 May 2001.
Revised on: 03 July 2001.
Accepted on: 31 August 2001.

___________________ImmunoTargets and Therapy---DOVE MEDICAL PRESS LTD

ellagic-acid 发表于 2025-3-23 21:25:35

Submitted on: 10 August 1998.
Revised on: 01 September 1998.
Accepted on: 07 October 1998.

___________________ImmunoTargets and Therapy---DOVE MEDICAL PRESS LTD

不愿 发表于 2025-3-23 22:42:01

http://reply.papertrans.cn/2/123/12298/12298-14.png

handle 发表于 2025-3-24 04:35:11

Submitted on: 10 September 2020.
Revised on: 15 December 2020.
Accepted on: 09 February 2021.

___________________ImmunoTargets and Therapy---DOVE MEDICAL PRESS LTD

RAFF 发表于 2025-3-24 08:45:05

http://reply.papertrans.cn/2/123/12298/12298-16.png

Liberate 发表于 2025-3-24 12:07:31

Submitted on: 27 June 2002.
Revised on: 05 October 2002.
Accepted on: 28 November 2002.

___________________ImmunoTargets and Therapy---DOVE MEDICAL PRESS LTD

羊栏 发表于 2025-3-24 17:07:10

http://reply.papertrans.cn/2/123/12298/12298-18.png

geriatrician 发表于 2025-3-24 20:30:48

http://reply.papertrans.cn/2/123/12298/12298-19.png

Adenoma 发表于 2025-3-25 00:20:19

Submitted on: 11 November 2011.
Revised on: 29 January 2012.
Accepted on: 28 March 2012.

___________________ImmunoTargets and Therapy---DOVE MEDICAL PRESS LTD
页: 1 [2] 3 4
查看完整版本: ESCI期刊ImmunoTargets and Therapy 2024/2025影响因子:6.289 (IMMUNOTARGETS THER) (NULL). (IMMUNOLOGY)(免疫学)Emerging Sources Cita